Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
The member of Girls Aloud are joining forces with us for a special ‘Race for Life for Sarah’, raising money for vital breast cancer research in honour of their much-loved bandmate.
Our scientists across the country are working hard to tackle drug resistance – one of cancer’s cruellest curveballs.
Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.
There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.
A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.
Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.
A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.
3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.
We spoke to three people about their experience of breast surgery and some of the difficult decisions they made along the way.
Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.